Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States

Arthritis Care and Research

Volumn 67, Issue 6, 2015, Pages 817-828

  Jarukitsopa, Sudumpai ^a   Hoganson, Deana D ^b   Crowson, Cynthia S ^c   Sokumbi, Olayemi ^d   Davis, Mark D ^c   Michet, Clement J ^c   Matteson, Eric L ^c   Maradit Kremers, Hilal ^c   Chowdhary, Vaidehi R ^c  

^a BUMRUNGRAD INTERNATIONAL HOSPITAL   (Thailand)

^b Mercy Arthritis and Osteoporosis Center   (United States)

^c MAYO CLINIC   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CAUCASIAN; CHILD; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PANNICULITIS; PREVALENCE; SEX DIFFERENCE; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; YOUNG ADULT; AGE; AGE DISTRIBUTION; ASIAN AMERICAN; EPIDEMIOLOGY; ETHNOLOGY; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TIME;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGE FACTORS; AGED; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 84929921373     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22502     Document Type: Article

References (50)

1. Gilliam JN, Sontheimer RD., Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981; 4: 471-5.
2. Tebbe B, Orfanos CE., Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6: 96-104.
3. Petri M., Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16: 847-58.
4. Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS., Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010; 39: 257-68.
5. Gronhagen CM, Fored CM, Granath F, Nyberg F., Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 2011; 164: 1335-41.
6. Durosaro O, Davis MD, Reed KB, Rohlinger AL., Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol 2009; 145: 249-53.
7. Rocca WA, Yawn BP, St. Sauver JL, Grossardt BR, Melton LJ III,. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012; 87: 1202-13.
8. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT., Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985; 60: 105-13.
9. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE., Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999; 42: 46-50.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. Sontheimer RD, Thomas JR, Gilliam JN., Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115: 1409-15.
12. Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT., High incidence and prevalence of systemic lupus erythematosus in Norway. Lupus 2012; 21: 1362-9.
13. Nossent HC., Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001; 28: 539-46.
14. Eilertsen GO, Becker-Merok A, Nossent JC., The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management. J Rheumatol 2009; 36: 552-9.
15. Gudmundsson S, Steinsson K., Systemic lupus erythematosus in Iceland 1975 through 1984: a nationwide epidemiological study in an unselected population. J Rheumatol 1990; 17: 1162-7.
16. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK., Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995; 38: 1260-70.
17. Alonso MD, Llorca J, Martinez-Vazquez F, Miranda-Filloy JA, Diaz de Teran T, Dierssen T, et al., Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore) 2011; 90: 350-8.
18. Jonsson H, Nived O, Sturfelt G, Silman A., Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 1990; 29: 185-8.
19. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G,: Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000; 27: 685-91.
20. Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ., Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum 2007; 57: 612-8.
21. Nightingale AL, Farmer RD, de Vries CS., Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 2007; 16: 144-51.
22. Hopkinson ND, Doherty M, Powell RJ., The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993; 32: 110-5.
23. Johnson AE, Gordon C, Palmer RG, Bacon PA., The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551-8.
24. Furst DE, Clarke AE, Fernandes AW, Bancroft T, Greth W, Iorga SR., Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus 2013; 22: 99-105.
25. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ., Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005; 14: 862-6.
26. Voss A, Green A, Junker P., Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998; 27: 98-105.
27. Laustrup H, Voss A, Green A, Junker P., Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol 2009; 38: 128-32.
28. Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, et al., Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 2014; 41: 680-7.
29. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C., The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheum 2014; 66: 357-68.
30. Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al., Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis Rheumatol 2014; 66: 369-78.
31. Nossent JC., Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis 1992; 51: 1197-201.
32. Flower C, Hennis AJ, Hambleton IR, Nicholson GD, Liang MH, and the Barbados National Lupus Registry Group. Systemic lupus erythematosus in an African Caribbean population: incidence, clinical manifestations, and survival in the Barbados National Lupus Registry. Arthritis Care Res (Hoboken) 2012; 64: 1151-8.
33. Vilar MJ, Sato EI., Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 2002; 11: 528-32.
34. Chiu YM, Lai CH., Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 2010; 19: 1250-5.
35. Mok CC, To CH, Ho LY, Yu KL., Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 2008; 35: 1978-82.
36. Molokhia M, McKeigue PM, Cuadrado M, Hughes G., Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK [letter]. Lancet 2001; 357: 1414-5.
37. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J., High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-2.
38. Mok CC., Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 2011; 20: 767-71.
39. Barnabe C, Joseph L, Belisle P, Labrecque J, Edworthy S, Barr SG, et al., Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res (Hoboken) 2012; 64: 138-43.
40. Nived O, Sturfelt G, Wollheim F., Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 1985; 24: 147-54.
41. Popovic K, Nyberg F, Wahren-Herlenius M, Nyberg F., A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum 2007; 56: 255-64.
42. Deligny C, Clyti E, Sainte-Marie D, Couppie P, Huong DL, Piette JC, et al., Incidence of chronic cutaneous lupus erythematosus in French Guiana: a retrospective population-based study. Arthritis Care Res (Hoboken) 2010; 62: 279-82.
43. Peters T, Weiss JM, Sindrilaru A, Wang H, Oreshkova T, Wlaschek M, et al., Reactive oxygen intermediate-induced pathomechanisms contribute to immunosenescence, chronic inflammation and autoimmunity. Mech Ageing Dev 2009; 130: 564-87.
44. Prelog M., Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006; 5: 136-9.
45. Harle P, Pongratz G, Weidler C, Buttner R, Scholmerich J, Straub RH., Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2004; 63: 809-16.
46. Lalani S, Pope J, de Leon F, Peschken C., Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol 2010; 37: 38-44.
47. Petri M, Orbai A, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-86.
48. Ng R, Bernatsky S, Rahme E., Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec. J Rheumatol 2013; 40: 1334-6.
49. Ward MM., Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol 2013; 40: 1241-3.
50. Bernatsky S, Linehan T, Hanly JG., The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011; 38: 1612-6.